From: Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
Clinical Variables | HR | 95% CI | P-value |
---|---|---|---|
Univariate analysis | |||
Age (≥60 vs <60) | 1.875 | 1.152-3.149 | 0.015 |
Gender (Male vs Female) | 1.267 | 0.589-2.627 | 0.365 |
TNM stage (III/IV vsI/II) | 3.396 | 2.133-5.548 | <0.001 |
Furhman grade (III/IV vsI/II) | 2.376 | 1.116-4.385 | 0.003 |
PFKFB3 (High vs Low) | 1.715 | 1.232-2.540 | <0.001 |
Multivariate analysis | |||
Age (≥60 vs <60) | 1.394 | 0.925-2.214 | 0.065 |
TNM stage (III/IV vsI/II) | 2.674 | 1.878-3.794 | <0.001* |
Furhman grade (III/IV vsI/II) | 1.751 | 1.130-2.812 | 0.009* |
PFKFB3 (High vs Low) | 1.358 | 1.028-2.791 | <0.001* |